Yizhen Xu

Vice President Clinical Development at Asklepios BioPharmaceutical, Inc. (AskBio) - Research Triangle Park, North Carolina, US

Yizhen Xu's Colleagues at Asklepios BioPharmaceutical, Inc. (AskBio)
Mark Marmur

Vice President, Corporate Communications

Contact Mark Marmur

Dean Mula

Vice President and Corporate Controller

Contact Dean Mula

Joy Carson

Vice President, Medical Communications and Publications

Contact Joy Carson

Sherif Ph.D.

Vice President of Research and Development

Contact Sherif Ph.D.

Mandeep Kaur

Durham - Chapel Hill Area - Senior Director, Human Resources

Contact Mandeep Kaur

Tricia Porter

Associate Director, Clinical Operations

Contact Tricia Porter

View All Yizhen Xu's Colleagues
Yizhen Xu's Contact Details
HQ
(919) 561-6210
Location
Company
Asklepios BioPharmaceutical, Inc. (AskBio)
Yizhen Xu's Company Details
Asklepios BioPharmaceutical, Inc. (AskBio) logo, Asklepios BioPharmaceutical, Inc. (AskBio) contact details

Asklepios BioPharmaceutical, Inc. (AskBio)

Research Triangle Park, North Carolina, US • 504 Employees
BioTech/Drugs

Asklepios BioPharmaceutical, Inc. (AskBio), a wholly owned and independently operated subsidiary of Bayer AG, is a fully integrated gene therapy company dedicated to developing life-saving medicines and changing lives. The company maintains a portfolio of clinical programs across a range of neuromuscular, central nervous system, cardiovascular and metabolic disease indications with a clinical-stage pipeline that includes therapeutics for congestive heart failure, Huntington’s disease, limb-girdle muscular dystrophy, multiple system atrophy, Parkinson’s disease, and Pompe disease. AskBio’s gene therapy platform includes Pro10™, an industry-leading proprietary cell line manufacturing process, and an extensive capsid and promoter library. With global headquarters in Research Triangle Park, North Carolina, and European headquarters in Edinburgh, Scotland, the company has generated hundreds of proprietary capsids and promoters, several of which have entered pre-clinical and clinical testing. Learn more at askbio.com. Vision - Pioneering science to create transformative molecular medicines. Mission - Lead innovative science and drive clinical outcomes to transform people's lives. Values: • Be a Pioneer. We are not afraid of the impossible and to innovate to make gene therapies accessible to those in need. • Cultivate Collaboration. Strive to be the best teammate, actively listen, openly communicate, and embrace diverse points of view. • Embrace Responsibility. We are humbled by the enormity of our mission. We hold a relentless commitment to advance science and clinical outcomes for our patients, families, and caregivers. • Raise the Bar. Continuously drive improvements and efficiencies. Seek and provide constructive feedback. Have a bias for learning and action. • Act with Uncompromising Integrity. Be honest, transparent, and committed to doing what’s right in every situation. Make clear commitments and follow through.

Gene Editing Neuromuscular Diseases Metabolic Diseases Cardiovascular Services Molecular Medicine Synthetic Biology Cgmp Manufacturing
Details about Asklepios BioPharmaceutical, Inc. (AskBio)
Frequently Asked Questions about Yizhen Xu
Yizhen Xu currently works for Asklepios BioPharmaceutical, Inc. (AskBio).
Yizhen Xu's role at Asklepios BioPharmaceutical, Inc. (AskBio) is Vice President Clinical Development.
Yizhen Xu's email address is ***@askbio.com. To view Yizhen Xu's full email address, please signup to ConnectPlex.
Yizhen Xu works in the BioTech/Drugs industry.
Yizhen Xu's colleagues at Asklepios BioPharmaceutical, Inc. (AskBio) are Mark Marmur, Dean Mula, Joy Carson, Michael Kranda, Sherif Ph.D., Mandeep Kaur, Tricia Porter and others.
Yizhen Xu's phone number is null
See more information about Yizhen Xu